The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar closes higher on Taipei forex market
05/09/2025 04:13 PM - Politics
Taiwan medical groups urge WHO to invite Taiwan to WHA as observer
05/09/2025 03:12 PM - Culture
Taiwanese architecture exhibition opens in Venice
05/09/2025 02:50 PM - Business
Taiwan shares close up 1.81%
05/09/2025 01:47 PM - Politics
Outgoing ambassador positive on Taiwan-Vatican ties under new pope
05/09/2025 12:44 PM